Evolving molecular subtyping of breast cancer advances precision treatment  

作　　者：Rui Shan Lei-Jie Dai Zhi-Ming Shao Yi-Zhou Jiang 

机构地区：[1]Department of Breast Surgery,Fudan University Shanghai Cancer Center,Shanghai 200032,China [2]Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China

出　　处：《Cancer Biology & Medicine》2024年第9期731-739,共9页癌症生物学与医学（英文版）

摘　　要：Breast cancer is the second most prevalent cancer globally.In 2022,approximately 2.3 million newly diagnosed cases of female breast cancer occurred worldwide,and more than 665 thousand people lost their lives to this disease^(1).

关 键 词：BREAST cancer BREAST 

分 类 号：R737.9[医药卫生—肿瘤]